SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-11-049421
Filing Date
2011-05-12
Accepted
2011-05-12 16:05:45
Documents
4
Period of Report
2011-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c17194e8vk.htm 8-K 10672
2 EXHIBIT 99.1 c17194exv99w1.htm EX-99.1 53212
3 GRAPHIC c17194c1719402.gif GRAPHIC 4955
4 GRAPHIC c17194c1719401.gif GRAPHIC 1860
  Complete submission text file 0000950123-11-049421.txt   74827
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 11835864
SIC: 2834 Pharmaceutical Preparations